Building Resilience @ Work Training Among Healthcare Workers (BRAW)

August 27, 2023 updated by: Lau Ying, National University of Singapore

Evaluation of Building Resilience at Work (BRAW) Training Among Healthcare Workers: A Sequential Mixed Methods Design

Background Given that the challenges in adjusting to shifting work, physical workload and high-strung nature, healthcare workers often encounter high stress, emotional exhaustion, low empathy, fatigue and burnout, which, in turn, result in sickness, absence, and high turnover. Hence, building resilience for future adversity among healthcare workers in the workplace is necessary.

Objectives To evaluate the effectiveness of the Building Resilience at Work (BRAW) on resilience, job engagement, intention to leave, employability, and work performance To explore healthcare workers' experience of the BRAW intervention.

Methods This study will evaluate the effectiveness of BRAW using a sequential mixed methods design in two phases. In phase I, a two-armed randomized controlled trial will be conducted to compare resilience, work engagement, coping skills, job satisfaction and life satisfaction with a waiting list control condition among 410 healthcare workers.

In phase II, the investigators will conduct a virtual individual interview to explore experiences on usability and acceptability after receiving the BRAW intervention using a sample of 33 healthcare workers.

Significance of research Considering the multifactorial and complexity of resilience at work in an increasingly dynamic healthcare environment, the content of resilience training can promote resilience, work engagement, coping skills, job satisfaction and life satisfaction among healthcare workers in order to reduce the turnover rate among healthcare workers in Singapore.

Study Overview

Status

Recruiting

Intervention / Treatment

Study Type

Interventional

Enrollment (Estimated)

410

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

21 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Healthcare workers aged 21 years or older
  • Can read English
  • Own and regularly use smartphone, tablet, laptop or desktop
  • Can access the internet

Exclusion Criteria:

  • Previous diagnosis of psychosis, severe depression, personality disorder and substance abuse at any point in their life

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: BRAW intervention group
BRAW is designed as an online intervention comprising of six sessions over six weeks. The six sessions are: (1) happiness and positivity, (2) cognitive restructuring, (3) behavioural activation, (4) emotion regulation, (5) positive work climate and (6) problem solving.

Sessions

  1. Happiness and positivity Understanding strengths and resilience and positive attitude
  2. Cognitive restructuring Identification dysfunctional automatic thoughts in problematic and emotional arousing situations Usage of cognitive -behavioural techniques to evaluate and modify dysfunctional thoughts and beliefs
  3. Behavioural activation Initiation and utilization of behavioural activation techniques for positive change by increasing pleasant events Healthy interpersonal relationships Importance of peer support
  4. Emotion regulation Preventing and managing conflict Emotion regulation abilities
  5. Positive work climate Building supportive work environment Development of supportive collegial relationships Promotion of coworker support
  6. Problem solving Problem-solving work-life problems Work-life balance Bringing it together
No Intervention: Waitlist control group
Participants will receive the intervention after the follow-up assessment.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Resilience
Time Frame: Baseline
A 6-item Brief Resilience Scale (BRS) is used to assess the ability to recover from stress. Items are rated on a 5-point Likert scale from 1 (strongly disagree) to 5 (strongly agree). The total score ranges from 6 to 30, with higher scores signifying greater bounce-back resilience. BRS has demonstrated good reliability and validity.
Baseline
Resilience
Time Frame: at 6 weeks
A 6-item Brief Resilience Scale (BRS) is used to assess the ability to recover from stress. Items are rated on a 5-point Likert scale from 1 (strongly disagree) to 5 (strongly agree). The total score ranges from 6 to 30, with higher scores signifying greater bounce-back resilience. BRS has demonstrated good reliability and validity.
at 6 weeks
Resilience
Time Frame: 12 weeks after training completes
A 6-item Brief Resilience Scale (BRS) is used to assess the ability to recover from stress. Items are rated on a 5-point Likert scale from 1 (strongly disagree) to 5 (strongly agree). The total score ranges from 6 to 30, with higher scores signifying greater bounce-back resilience. BRS has demonstrated good reliability and validity.
12 weeks after training completes

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Work engagement
Time Frame: Baseline
A 9-item Utrecht Working Engagement Scale short version (UWES-9) is used to measure the participant's feelings in the context of work. Participant rate how often they experience these feelings on a 4-point Likert scale from 1 (never) to 4 (always). The total score ranges from 9 to 36 and higher scoring on UWES-9 indicates more work engagement. UWES-9 has confirmed satisfactory validity and reliability.
Baseline
Work engagement
Time Frame: at 6 weeks
A 9-item Utrecht Working Engagement Scale short version (UWES-9) is used to measure the participant's feelings in the context of work. Participant rate how often they experience these feelings on a 4-point Likert scale from 1 (never) to 4 (always). The total score ranges from 9 to 36 and higher scoring on UWES-9 indicates more work engagement. UWES-9 has confirmed satisfactory validity and reliability.
at 6 weeks
Work engagement
Time Frame: 12 weeks after training completes
A 9-item Utrecht Working Engagement Scale short version (UWES-9) is used to measure the participant's feelings in the context of work. Participant rate how often they experience these feelings on a 4-point Likert scale from 1 (never) to 4 (always). The total score ranges from 9 to 36 and higher scoring on UWES-9 indicates more work engagement. UWES-9 has confirmed satisfactory validity and reliability.
12 weeks after training completes
Intention to leave
Time Frame: Baseline
12-item Anticipated Turnover Scale (ATS)49 is used to measure intention to leave. Questions are related to one's anticipated length of time before leaving and certainty of leaving the job. Items are rated on a 5-point Likert scale from 1 (strongly disagree) to 5 (strongly agree). The total score ranges from 12 to 60, with higher scores reflecting higher degree of turnover. CVI was 0.80-0.95 for items. Cronbach's alphas were 0.85-0.94 in several researches. Test-retest reliability coefficient was 0.84 in 2 weeks' interval.
Baseline
Intention to leave
Time Frame: at 6 weeks
12-item Anticipated Turnover Scale (ATS)49 is used to measure intention to leave. Questions are related to one's anticipated length of time before leaving and certainty of leaving the job. Items are rated on a 5-point Likert scale from 1 (strongly disagree) to 5 (strongly agree). The total score ranges from 12 to 60, with higher scores reflecting higher degree of turnover. CVI was 0.80-0.95 for items. Cronbach's alphas were 0.85-0.94 in several researches. Test-retest reliability coefficient was 0.84 in 2 weeks' interval.
at 6 weeks
Intention to leave
Time Frame: 12 weeks after training completes
12-item Anticipated Turnover Scale (ATS)49 is used to measure intention to leave. Questions are related to one's anticipated length of time before leaving and certainty of leaving the job. Items are rated on a 5-point Likert scale from 1 (strongly disagree) to 5 (strongly agree). The total score ranges from 12 to 60, with higher scores reflecting higher degree of turnover. CVI was 0.80-0.95 for items. Cronbach's alphas were 0.85-0.94 in several researches. Test-retest reliability coefficient was 0.84 in 2 weeks' interval.
12 weeks after training completes
Employability
Time Frame: Baseline
A 11-item Self-perceived Employability Scale (SPE) is used to assess employability. Participants are required to state their agreement with the items by selecting a number on a 5-point scale, from 1 (strong disagreement) to 5 (strong agreement). The total score ranges from 11 to 55, with higher score indicating perceived better employability. SPE has reported good internal consistency
Baseline
Employability
Time Frame: at 6 weeks
A 11-item Self-perceived Employability Scale (SPE) is used to assess employability. Participants are required to state their agreement with the items by selecting a number on a 5-point scale, from 1 (strong disagreement) to 5 (strong agreement). The total score ranges from 11 to 55, with higher score indicating perceived better employability. SPE has reported good internal consistency
at 6 weeks
Employability
Time Frame: 12 weeks after training completes
A 11-item Self-perceived Employability Scale (SPE) is used to assess employability. Participants are required to state their agreement with the items by selecting a number on a 5-point scale, from 1 (strong disagreement) to 5 (strong agreement). The total score ranges from 11 to 55, with higher score indicating perceived better employability. SPE has reported good internal consistency
12 weeks after training completes
Work performance
Time Frame: Baseline
A 18-item Individual Work Performance Questionnaire (IWPQ) is used to measure individual work performance. The IWPQ has a recall period of 3 months and a rating scale from 0 (seldom/never) to 4 (always/often) for task, contextual performance and counterproductive work behaviour. A mean score is calculated by adding the item scores, and dividing their sum by the number of items that range between 0 and 4, with higher scores reflecting higher individual work performance. The psychometric properties of the IWPQ indicated excellent internal consistency and good validity.
Baseline
Work performance
Time Frame: at 6 weeks
A 18-item Individual Work Performance Questionnaire (IWPQ) is used to measure individual work performance. The IWPQ has a recall period of 3 months and a rating scale from 0 (seldom/never) to 4 (always/often) for task, contextual performance and counterproductive work behaviour. A mean score is calculated by adding the item scores, and dividing their sum by the number of items that range between 0 and 4, with higher scores reflecting higher individual work performance. The psychometric properties of the IWPQ indicated excellent internal consistency and good validity.
at 6 weeks
Work performance
Time Frame: 12 weeks after training completes
A 18-item Individual Work Performance Questionnaire (IWPQ) is used to measure individual work performance. The IWPQ has a recall period of 3 months and a rating scale from 0 (seldom/never) to 4 (always/often) for task, contextual performance and counterproductive work behaviour. A mean score is calculated by adding the item scores, and dividing their sum by the number of items that range between 0 and 4, with higher scores reflecting higher individual work performance. The psychometric properties of the IWPQ indicated excellent internal consistency and good validity.
12 weeks after training completes
Usage and satisfaction of training
Time Frame: at 6 weeks
Usage is defined as an encompassing engagement, i.e., the time (in minutes) spent browsing the website and practicing the assigned homework in the previous weeks. Computer-generated indicators include the following: (1) session completion, (2) number of website visits, and (3) time spent on the website. At the end of the six-week program, attitude toward and satisfaction with the online training will be assessed using the self-developed eight-item usage and satisfaction of training. Each item is rated on a 4-point Likert scale from 1 to 4, and response options differed for the various items. The total score ranges from 8 to 32, and a high score represents better satisfaction of training. In addition, we have four open questions to obtain suggestions for improvement.
at 6 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Ying Lau, PhD, Chinese University of Hong Kong

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 20, 2021

Primary Completion (Estimated)

December 31, 2024

Study Completion (Estimated)

December 31, 2024

Study Registration Dates

First Submitted

November 10, 2021

First Submitted That Met QC Criteria

November 19, 2021

First Posted (Actual)

November 23, 2021

Study Record Updates

Last Update Posted (Actual)

August 30, 2023

Last Update Submitted That Met QC Criteria

August 27, 2023

Last Verified

August 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • WF19-14

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Resilience, Psychological

Clinical Trials on BRAW

  • University of Nevada, Las Vegas
    Recruiting
    TBI (Traumatic Brain Injury) | Exercise | Brain Concussion | Rehabilitation | Walking | Cognition | Clinical Trial | Psychosocial Functioning | microRNA | Mobile Application | Saliva | Vision, Ocular
    United States
3
Subscribe